Deutsche Bank’s Rosetta Genomics ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
Deutsche Bank's ROSG Position: Q1 2018 in Review
Deutsche Bank sold out of Rosetta Genomics (ROSG) in Q1 2018, closing a stake of 2 shares.
Deutsche Bank first reported a position in ROSG in Q3 2017 and held it in 2 quarters. The position peaked at $0 in Q4 2017. 8 funds tracked by Wall St. Rank hold ROSG as of Q1 2018.
- Deutsche Bank reported no remaining Rosetta Genomics position as of Q1 2018 after selling out during the quarter.
- Deutsche Bank sold 2 Rosetta Genomics shares in Q1 2018.
- Deutsche Bank first reported a position in Rosetta Genomics in Q3 2017 and held it in 2 quarters.
- Deutsche Bank's Rosetta Genomics position peaked at $0 in Q4 2017.
- 8 funds tracked by Wall St. Rank held Rosetta Genomics as of Q1 2018.
Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.